For research use only. Not for human or veterinary use. 21+.
Buy one, get one freeOn every vial · no code neededShop the offer
MANUFACTURED & SHIPPED FROM THE USA
Wolverine Blend 20 mg — Peptides Only, research use only
BPC-157 + TB-500 · Recovery & Repair

Wolverine Blend

99.897% purity · Lot 1000001 · tested Feb 20, 2026

BPC-157 and TB-500 combined 1:1 for tissue-repair research.

  • Independently tested
  • Lot-matched COA
  • Lyophilized for stability
  • Ships from the USA
Research use only. Not for human or veterinary use. Sold to qualified researchers aged 21+.
$195.002 for $195 — $97.50 per vial
Buy one, get one free. Mix and match any 2 eligible vials and the lower-priced one is free — applied automatically. One-time purchases only.
1
Wolverine Blend$195.002 for $195
Lot-matched documentation. Every order ships with the certificate for its lot. If a vial arrives damaged or doesn't match its paperwork, tell us within 72 hours and we'll replace it.

Latest lab results

Third-party tested

Wolverine Blend 20 mg

Purity (HPLC-UV)
99.897%
Identity (LC-MS)
Confirmed — BPC-157 / Thymosin Beta-4
Net content
BPC-157 11.66 mg / TB-500 10.14 mg (label 20 mg)
Lot
1000001
Tested
Feb 20, 2026
Lab
Freedom Diagnostics Testing
View certificate (PDF)

Your order ships with the certificate for its own lot.

About Wolverine Blend

BPC-157 and TB-500 combined 1:1 for tissue-repair research.

Supplied as

20 mg per vial, as a lyophilized powder in a sealed glass vial with a crimped cap. The lot number on the label matches the certificate of analysis in the COA library.

Storage and handling

Store lyophilized powder frozen (−20 °C) or refrigerated, sealed and away from light. Once reconstituted, keep refrigerated (2–8 °C).

Handle in a laboratory setting using appropriate protective equipment. Consult the certificate of analysis and safety data for lot-specific information.

Important research notice. This product is intended solely for in-vitro and laboratory research. It is not a drug, food, supplement or cosmetic, has not been evaluated by the FDA, and must not be used in humans or animals. Peptides Only does not provide usage or dosing information.

Research summary

Wolverine Blend is a single lyophilized vial that combines BPC-157 and TB-500 in a 1:1 ratio, 20 mg in total. It pairs two of the most-studied peptides in tissue-repair research, which have been examined in overlapping injury models through different proposed mechanisms. No published study has tested this exact pre-mixed blend.

Also known as
BPC-157 + TB-500 blend · BPC-157/TB-500 blend · Wolverine peptide blend
Sequence
BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val; TB-500: Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln

What is in the vial?

BPC-157 is a 15-amino-acid peptide whose sequence is a partial sequence of a protein found in human gastric juice1. TB-500 is the seven-amino-acid, N-terminally acetylated 17-23 fragment of thymosin beta-4, Ac-LKKTETQ2. The two are unrelated in structure and origin; the blend supplies both in one vial, in equal amounts by mass. Every lot ships with a lot-matched certificate of analysis from an independent lab, published in the certificate library.

Why BPC-157 and TB-500 are studied together

Each peptide has been linked, in separate studies, to cell migration and new blood-vessel formation, two processes central to tendon and soft-tissue repair models, but by different routes. BPC-157 increased tendon fibroblast migration through FAK-paxillin signaling1 and activated VEGFR2-Akt-eNOS signaling in endothelial cells3. The actin-binding motif that TB-500 reproduces was found to be essential for thymosin beta-4's angiogenic activity and matched the full protein in endothelial migration assays4.

The research behind each component

Each component has its own preclinical record:

  • BPC-157: in rats with transected Achilles tendons it was associated with higher load to failure, better functional scores and more complete repair than controls5, and a 2019 review found consistently positive results across rodent tendon, ligament and muscle models6.
  • TB-500: the synthetic peptide LKKTETQ promoted dermal wound repair in aged mice comparably to full-length thymosin beta-47.

What has been tested in combination

One study has given the two peptides together. In a 2026 rat Achilles tendon repair experiment with four groups of eight (control, BPC-157, TB-500 and both), TB-500 alone produced a significant biomechanical advantage and better histology scores, BPC-157 alone showed numerically better scores that did not reach significance, and the combination did not outperform either peptide alone8. The authors suggested the two may converge on shared downstream pathways, a hypothesis they noted still needs testing8.

Limitations of the evidence

No published study has tested the Wolverine Blend or any pre-mixed 1:1 BPC-157 and TB-500 formulation, and there are no published data on how the two peptides behave together in one vial over time. No controlled human study of the combination has been published, and human data for BPC-157 alone consist of three small uncontrolled studies9. For a side-by-side of the components, see BPC-157 vs TB-500.

Wolverine Blend FAQ

Has the Wolverine Blend been studied?

Not as a product. No published study tests this exact pre-mixed blend. The closest is a 2026 rat Achilles tendon study that gave both peptides together and found no improvement over either alone8.

What ratio of BPC-157 to TB-500 does Wolverine Blend contain?

The vial contains the two peptides in a 1:1 ratio by mass, 20 mg in total, as a lyophilized powder. The ratio is a product specification, not a value taken from a published study.

How does Wolverine Blend differ from the GLOW and KLOW blends?

Wolverine contains only BPC-157 and TB-500. The GLOW Blend adds GHK-Cu, and the KLOW Blend adds GHK-Cu and KPV. The GLOW vs KLOW vs Wolverine article compares all three.

Are BPC-157 and TB-500 prohibited in sport?

Yes. The World Anti-Doping Agency's 2026 Prohibited List names BPC-157 in class S0 (non-approved substances) and thymosin beta-4 and its derivatives, such as TB-500, in class S2. Both classes are prohibited at all times.

Further reading

References

  1. Chang CH, Tsai WC, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011;110(3):774-80. PubMed 21030672
  2. Esposito S, Deventer K, et al. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug Test Anal. 2012;4(9):733-8. PubMed 22962027
  3. Hsieh MJ, Liu HT, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017;95(3):323-333. PubMed 27847966
  4. Philp D, Huff T, et al. The actin binding site on thymosin beta4 promotes angiogenesis. FASEB J. 2003;17(14):2103-5. PubMed 14500546
  5. Staresinic M, Sebecic B, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-83. PubMed 14554208
  6. Gwyer D, Wragg NM, et al. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153-159. PubMed 30915550
  7. Philp D, Badamchian M, et al. Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen. 2003;11(1):19-24. PubMed 12581423
  8. Biçer O, Adanir O, et al. Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study. Jt Dis Relat Surg. 2026;37(3):822-837. PubMed 42542926
  9. Poolton JT, Minett J, et al. Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety. Acta Orthop Belg. 2026;92(3). PubMed 42885452

Research summary reviewed 2026-10-26 against the cited literature.

More Blends

You might also need

View all
GLOW Blend 70 mg — Peptides Only, research use onlyBuy One Get One
Lyophilized vial

GLOW Blend

GHK-Cu, BPC-157 and TB-500 blended for skin-matrix research.

$200.00
2 for $200 · $100/vial

Contact Peptides Only

Operated by DND Wellness LLC · 1309 Coffeen Ave, Suite 1200, Sheridan, WY 82801.

support@peptides-only.com · (508) 404-8124

Use the chat widget to ask a question. Informational and promotional text messages require separate, optional consent. Message frequency varies. Msg & data rates may apply. Reply STOP to unsubscribe or HELP for help. Consent is not a condition of purchase. 21+.

SMS consent & support · SMS terms & Terms of Service · Privacy Policy